The anti-COVID-19 Sputnik V vaccine was approved by the Ministry of Health of Mongolia, reports the Russian Direct Investment Fund (RDIF).
Registration was carried out as part of an accelerated procedure (emergency use authorization) without conducting additional clinical studies on the territory of the state. Vaccine approval was obtained with the assistance of the local partner of RDIF – Mongolian pharmaceutical company Mongol Emimpex Concern LLC.
“Partners in Mongolia decided to register the vaccine after study of Sputnik V clinical research data that demonstrated its high efficacy and safety, which is also confirmed by a publication in The Lancet journal. Sputnik V is one of the leading vaccines in the world, and the number of countries approved it”, said Kirill Dmitriev, CEO of the RDIF.
Mongolia became the 23rd country in the world approved the use of the Sputnik V vaccine. Previously, the drug was approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar and Pakistan.
